SNMMI In The News

January 29, 2013

Amyloid Imaging Guideline Issued

MedPage Today

Use of new, FDA-approved imaging technologies for beta-amyloid protein plaques in the brain should be limited to a relatively small subset of individuals, according to a new guideline issued jointly by the Alzheimer's Association and the Society for Nuclear Medicine and Molecular Imaging.

Related Items